JORGE CASTILLO to Remission Induction
This is a "connection" page, showing publications JORGE CASTILLO has written about Remission Induction.
Connection Strength
0.269
-
Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenstr?m's macroglobulinemia. Blood. 2014 Jul 24; 124(4):503-10.
Score: 0.107
-
Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: a unifying diagnosis. Am J Hematol. 2011 Aug; 86(8):690-3.
Score: 0.087
-
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood. 2014 Oct 09; 124(15):2354-61.
Score: 0.027
-
Cellular immunotherapy for refractory hematological malignancies. J Transl Med. 2013 Jun 19; 11:150.
Score: 0.025
-
EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru. Am J Hematol. 2011 Aug; 86(8):663-7.
Score: 0.022